🔎 Trials Near Me

Почетна › Рак на бешиката › Вашингтон

Клинички испитувања за Рак на бешиката во Вашингтон

25 студии за Рак на бешиката бараат учесници на локации во Вашингтон.

Градови во Вашингтон

Официјален текст на студијата (англиски)

The Vanguard Study: Testing a New Way to Screen for Cancer

  • Madigan Army Medical Center, Tacoma
Се регрутираДобредојдени се здрави волонтери
Возраст од 45 до 75 · Сите полови · Ажурирано 5.10.2026 · NCT06995898

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Providence Regional Cancer System-Aberdeen, Aberdeen
  • PeaceHealth Saint Joseph Medical Center, Bellingham
  • Providence Regional Cancer System-Centralia, Centralia
  • и уште 19
Се регрутираНабљудувачка студијаДобредојдени се здрави волонтери
Возраст од 40 до 75 · Сите полови · Ажурирано 2.10.2026 · NCT05334069

A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)

  • University of Washington - Fred Hutchinson Cancer Center ( Site 0100), Seattle
Се регрутираФаза 2
Возраст 18 и постари · Сите полови · Ажурирано 1.10.2026 · NCT06833073

Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial

  • Fred Hutchinson Cancer Center, Seattle
  • Swedish Medical Center-First Hill, Seattle
  • University of Washington Medical Center - Montlake, Seattle
Се регрутираФаза 2
Возраст 18 и постари · Сите полови · Ажурирано 1.10.2026 · NCT07061964

Enfortumab Vedotin, Pembrolizumab and Quemliclustat for the Treatment of Unresectable Locally Advanced and Metastatic Urothelial Cancer

  • Fred Hutch/University of Washington Cancer Consortium, Seattle
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 30.9.2026 · NCT07667335

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

  • Valley Medical Center, Renton
Се регрутираФаза 2
Возраст 18 и постари · Сите полови · Ажурирано 30.9.2026 · NCT03866382

Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer

  • Eye Associates Northwest - Edmonds Clinic, Edmonds
  • Eye Associates Northwest - Kirkland Clinic, Kirkland
  • Eye Associates Northwest - Ballard Clinic and Surgery Center, Seattle
  • и уште 6
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 28.9.2026 · NCT07421700

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

  • Swedish Cancer Institute, Seattle
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 28.9.2026 · NCT07277413

A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)

  • Fred Hutchinson Cancer Research Center ( Site 0787), Seattle
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 25.9.2026 · NCT07419295

Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors

  • University of Washington Fred Hutchinson Cancer Center, Seattle
Се регрутираФаза 1/2
Возраст од 18 до 99 · Сите полови · Ажурирано 22.9.2026 · NCT06814496

A Home-Based Prehabilitation Exercise Intervention for Improving Physical Function in Patients With Bladder Cancer and Upper Tract Urothelial Cancer, Get Moving Trial

  • Fred Hutch/University of Washington Cancer Consortium, Seattle
Се регрутира
Возраст 18 и постари · Сите полови · Ажурирано 10.9.2026 · NCT06040762

Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC

  • Spokane Urology, Spokane
Се регрутираФаза 2
Возраст 18 и постари · Сите полови · Ажурирано 3.9.2026 · NCT06567743

Consolidative Therapy After EV + Pembrolizumab in Muscle Invasive Bladder Cancer, REINFORCE Trial

  • Fred Hutch/University of Washington Cancer Consortium, Seattle
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 25.8.2026 · NCT07579195

Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer

  • Spokane Urology, Spokane
Се регрутираФаза 2
Возраст 18 и постари · Сите полови · Ажурирано 24.8.2026 · NCT05951179

Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer

  • Fred Hutch/University of Washington Cancer Consortium, Seattle
Се регрутираНабљудувачка студијаДобредојдени се здрави волонтери
Возраст 18 и постари · Мажи · Ажурирано 6.8.2026 · NCT01050504

Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2

  • Fred Hutch/University of Washington Cancer Consortium, Seattle
Се регрутираНабљудувачка студија
Возраст 18 и постари · Сите полови · Ажурирано 31.7.2026 · NCT07225127

Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy

  • Local Institution - 0200, Seattle
  • Fred Hutchinson Cancer Center, Seattle
  • University of Washington Medical Center - Montlake, Seattle
Се регрутираФаза 2/3
Возраст 18 и постари · Сите полови · Ажурирано 29.7.2026 · NCT07106762

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

  • University of Washington School of Medicine, Seattle
Се регрутираФаза 2
Возраст 8 и постари · Сите полови · Ажурирано 27.7.2026 · NCT05503797

A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

  • Harborview Medical Center, Seattle
  • Fred Hutchinson Cancer Center, Seattle
  • University of Washington Medical Center, Seattle
Се регрутираФаза 2
Возраст 18 и постари · Сите полови · Ажурирано 22.7.2026 · NCT04879329

An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC

  • Research Site, Seattle
  • Research Site, Tacoma
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 22.7.2026 · NCT07720284

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

  • Northwest Medical Specialities. PLLC, Bonney Lake
  • Swedish Cancer Institute - Edmonds Campus, Edmonds
  • Swedish Cancer Institute Edmonds Campus, Edmonds
  • и уште 9
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 6.7.2026 · NCT04389632

Home-Based Physical Activity Program With Digital App Versus Health Education Group for Improving Physical Activity Among Patients With Non-muscle Invasive Bladder Cancer, The EMPOWER Trial

  • Fred Hutch/University of Washington Cancer Consortium, Seattle
Се регрутира
Возраст 18 и постари · Сите полови · Ажурирано 6.7.2026 · NCT07302230

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

  • Fred Hutchinson Cancer Center, Seattle
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 13.2.2026 · NCT06778863

Blue Light Cystoscopy With Cysview® Registry

  • University of Washington Medicine, Seattle
Се регрутираНабљудувачка студија
Возраст 18 и постари · Сите полови · Ажурирано 18.12.2025 · NCT02660645

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Seattle
Се регрутираНабљудувачка студија
Сите возрасти · Сите полови · Ажурирано 28.10.2025 · NCT03452774

Од ClinicalTrials.gov, податоци преземени 6.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.